The rising prevalence of cancer worldwide, increasing adoption of minimally invasive diagnostic tests, and advances in ...

The integrated platform decreases manual effort by 30–50%, reduces total expenses by up to 25%, and speeds up turnaround ...

This infographic will explore how NGS has contributed to advances in personalized cancer treatment, microbiome research and ...

SOPHiA Genetics & Jessa Ziekenhuis partner to bring cutting edge genomic testing and oncology research to cancer patients across Belgium: Boston Monday, September 8, 2025, 16:00 H ...